The impact of ANG II and IV on INS-1 cells and on blood glucose and plasma insulin

References

• Ramracheya RD, Muller DS, Wu Y, Whitehouse BJ, Huang GC, Amiel SA, Karalliedde J, Viberti G, Jones PM, Persaud SJ. Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans. Diabetologia 2006, 49, 321–31.
   PubMed Web of Science ®Google Scholar
• Leung PS. The physiology of a local renin–angiotensin system in the pancreas. J Physiol 2007, 580, 31–7. (Kopie bei mir)
   Web of Science ®Google Scholar
• Lew RA, Mustafa T, Ye S, McDowall SG, Chai SY, Albiston AL. Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). J Neurochem 2003, 86, 344–50.
   PubMed Web of Science ®Google Scholar
• Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, Lee J, Mendelsohn FA, Simpson RJ, Connolly LM, Chai SY. Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 2001, 276, 48623–6.
   PubMed Web of Science ®Google Scholar
• Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim, CB. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 1992, 130, 167–78.
   PubMed Web of Science ®Google Scholar
• Verspohl EJ. Recommended testing in diabetes research. Planta Med 2002, 68, 581–90.
   PubMed Web of Science ®Google Scholar
• Chappell MC, Jacobsen DW, Tallant EA. Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cells. Peptides 1995, 16, 741–7.
   PubMed Web of Science ®Google Scholar
• Chu KY, Lau T, Carlsson PO, Leung PS. Angiotens II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 2006, 55, 367–74.
   PubMed Web of Science ®Google Scholar
• Lau T, Carlsson PO, Leung PS. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 2004, 47, 240–8.
   PubMed Web of Science ®Google Scholar
• Tahmasebi M, Puddefoot JR, Inwang ER, Vinson GP. The tissue renin–angiotensin system in human pancreas. J Endocrinol 1999, 161, 317–22.
   PubMed Web of Science ®Google Scholar
• Zhang JH, Hanesworth JM, Sardinia MF, Alt JA, Wright JW, Harding JW. Structural analysis of angiotensin IV receptor (AT4) from selected bovine tissues. J Pharmacol Exp Ther 1999, 289, 1075–83.
   PubMed Web of Science ®Google Scholar
• Weiland F, Verspohl EJ. Local formation of angiotensin peptides with paracrine activity by adipocytes. J Pept Sci 2009, 15, 767–76.
   PubMed Web of Science ®Google Scholar
• Krishnan R, Hanesworth JM, Wright JW, Harding JW. Structure-binding studies of the adrenal AT4 receptor: analysis of position two- and three-modified angiotensin IV analogs. Peptides 1999, 20, 915–20.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Nomura S, Mitsui T, Ito T, Kuno N, Ohno Y, Kadomatsu K, Muramatsu T, Nagasaka T, Mizutani S. Tissue distribution of placental leucine aminopeptidase/oxytocinase during mouse pregnancy. J Histochem Cytochem 2004a, 52, 113–21.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Mitsui T, Nomura S, Ohno Y, Kadomatsu K, Muramatsu T, Nagasaka T, Mizutani S. Expression of glucose transporter 4 in the human pancreatic islet of Langerhans. Biochem Biophys Res Commun 2004b, 314, 1121–5.
   PubMed Web of Science ®Google Scholar
• Herbst JJ, Ross SA, Scott HM, Bobin SA, Morris NJ, Lienhard GE, Keller SR. Insulin stimulates cell surface aminopeptidase activity toward vasopressin in adipocytes. Am J Physiol 1997, 272, 600–6.
   Google Scholar
• Ammon HPT, Reiber C, Verspohl EJ. Indirect evidence for short-loop negative feedback of insulin secretion in the rat. J Endocrinol 1991, 128, 27–34.
   PubMed Web of Science ®Google Scholar
• Kandror KV, Pilch PF. GP160, a tissue-specific marker for insulin-activated glucose transport. Proc Natl Acad Sci U S A 1994, 91, 8017–21.
   PubMedGoogle Scholar
• Thoidis G, Kandror KV. A Glut4-vesicle marker protein, insulin-responsive aminopeptidase, is localized in a novel vesicular compartment in PC12 cells. Traffic 2001, 2, 577–87.
   PubMed Web of Science ®Google Scholar
• Keller SR, Davis AC, Clairmont KB. Mice deficient in the insulin-regulated membrane aminopeptidase show substantial decreases in glucose transporter GLUT4 levels but maintain normal glucose homeostasis. J Biol Chem 2002, 277, 17677–86.
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Itakura A, Okada M, Mizutani S, Kikkawa F. Impaired insulin-regulated membrane aminopeptidase translocation to the plasma membrane in adipocytes of Otsuka Long Evans Tokushima Fatty rats. Nagoya J Med Sci 2006, 68,155–63.
   PubMedGoogle Scholar
• Werner G, Hagenmaier H, Drautz H, Baumgartner A, Zahner H. Metabolic products of microorganisms. 224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity. J Antibiot (Tokyo)1984, 37, 110–7.
   PubMed Web of Science ®Google Scholar
• Ghiani BU, Masini MA. Angiotensin II binding sites in the rat pancreas and their modulation after sodium loading and depletion. Comp Biochem Physiol A Physiol 1995, 111, 439–44.
   PubMed Web of Science ®Google Scholar
• Greenland K, Wyse B, Sernia C. Identification and characterization of angiotensinIV binding sites in rat neurone and astrocyte cell cultures. J Neuroendocrinol 1996, 8, 687–93.
   PubMed Web of Science ®Google Scholar
• Handa RK, Harding JW, Simasko SM. Characterization and function of the bovine kidney epithelial angiotensin receptor subtype 4 using angiotensin IV and divalinal angiotensin IV as receptor ligands. J Pharmacol Exp Ther 1999, 291, 1242–9.
   PubMed Web of Science ®Google Scholar
• Wang L, Eberhard M, Kohler E. Erne PA specific binding site for angiotensin II(3–8), angiotensin IV, in rabbit cardiac fibroblasts. J Recept Signal Transduct Res 1995, 15, 517–27.
   PubMed Web of Science ®Google Scholar
• Reaux A, Fournie-Zaluski MC, David C, Zini S, Roques BP, Corvol P, Llorens-Cortes C. Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci U S A 1999, 96, 13415–20.
   PubMed Web of Science ®Google Scholar
• Wyse B, Greenland K, Sernia C. Specific binding sites for (3–8)angiotensin in C6 glioma cells. Brain Res 1995, 681, 41–6.
   PubMed Web of Science ®Google Scholar
• Weiland F, Verspohl EJ. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes. Horm Metab Res 2008, 40, 760–6.
   PubMed Web of Science ®Google Scholar
• Dulin N, Madhun ZT, Chang CH, Berti-Mattera L, Dickens D, Douglas JG. Angiotensin IV receptors and signaling in opossum kidney cells. Am J Physiol 1995, 269, 644–52.
   PubMedGoogle Scholar
• Huang Z, Jansson L, Sjoholm A. Pancreatic islet blood flow is selectively enhanced by captopril, irbesartan and pravastatin, and suppressed by palmitate. Biochem Biophys Res Commun 2006, 346, 26–32.
   PubMed Web of Science ®Google Scholar
• Huang Z, Jansson L, Sjoholm A. Vasoactive drugs enhance pancreatic islet blood flow, augment insulin secretion and improve glucose tolerance in female rats. Clin Sci (Lond)2007, 112, 69–76.
   Web of Science ®Google Scholar
• Carlsson PO, Berne C, Jansson L. Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 1998, 41, 127–33.
   PubMed Web of Science ®Google Scholar
• Wong PF, Lee SS, Cheung WT. Immunohistochemical colocalization of type II angiotensin receptors with somatostatin in rat pancreas. Regul Pept 2004, 117, 195–205.
   PubMedGoogle Scholar
• Szekeres M, Turu G, Orient A, Szalai B, Süpeki K, Cserzo M, Várnai P, Hunyady L. Mechanism of angiotensin II-mediated regulation of aldosterone synthase expression in H29R human adrenocortical and rat adrenal glomerulosa cells. Mol Cell Endocrinol 2009, 302, 244–53.
   PubMed Web of Science ®Google Scholar
• Aplin M, Christensen GL, Schneider M, Heydorn A, Gammeltoft S, Kjoelbye AL, Sheikh SP, Hansen JL. Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytes. Basic Clin Pharmacol Toxicol 2007, 100, 296–301.
   PubMed Web of Science ®Google Scholar
• Aplin M, Christensen GL, Schneider M, Heydorn A, Gammeltoft S, Kjoelbye AL, Sheikh SP, Hansen JL. The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and Langendorff-perfused hearts. Basic Clin Pharmacol Toxicol 2007, 100, 289–95.
   PubMed Web of Science ®Google Scholar
• Daniels D, Yee DK, Faulconbridge LF, Fluharty SJ. Divergent behavioural roles of angiotensin receptor intracellular signaling cascades. Endocrinology 2005, 146, 5552–60.
   PubMed Web of Science ®Google Scholar
• Gesualdo L, Ranieri E, Monno R, Rossiello MR, Colucci M, Semeraro N, Grandaliano G, Schena FP. Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells. Kidney Int 1999, 56, 461–70.
   PubMed Web of Science ®Google Scholar
• Skurk T, Lee YM, Röhrig K, Hauner H. Effect of angiotensin peptides on PAI-1 expression and production in human adipocytes. Horm Metab Res 2001; 33:196–200.
   PubMed Web of Science ®Google Scholar